At 1.40 p.m. EST, the Dow Jones Industrial Average rose 23.16 points, or 0.09 percent, to 24,762.69. The S&P 500 fell 0.95 points, or 0.03 percent, to 2,722.12. The Nasdaq Composite dropped 18.82 points, or 0.25 percent, to 7,386.15.
Cronos Group Inc (NASDAQ: CRON) has grabbed attention from the analysts when it experienced a change of 7.30% in the current trading session to trade at $6.01. A total of 1,803,074 shares exchanged hands during the intra-day trade contrast with its average trading volume of 2.41M shares, while its relative volume stands at 1.28. Relative volume is the comparison of current volume to average volume for the same time of day, and it’s displayed as a ratio. If RVOL is less than 1 it is not In Play on this trading day and Investors may decide not to trade it. If RVOL is above 2 it is In Play and this is more evidence Investors ought to be in the name. When stocks are *very* In Play one can see a RVOL of 5 and above. The higher the RVOL the more In Play the stock is.
Cronos Group Inc. will release its financial results for the first quarter ended March 31, 2018 before the market opens on May 15, 2018.
The Company will host a conference call with Mike Gorenstein, Chief Executive Officer, and William Hilson, Chief Financial Officer, on Tuesday, May 15, 2018 at 8:00 a.m. EST to discuss first quarter 2018 results.
Volatility is simply a measure of the predictable daily price range—the range in which a day trader operates. More volatility means greater profit or loss. After a recent check, Cronos Group Inc (NASDAQ: CRON) stock is found to be 4.07% volatile for the week, while 5.77% volatility is recorded for the month.
The stock has a market cap of $798.86M and the number of outstanding shares has been calculated 142.65M. Based on a recent bid, its distance from 20 days simple moving average is -8.98%, and its distance from 50 days simple moving average is -17.16% while it has a distance of 23.75% from the 200 days simple moving average. The company’s distance from 52-week high price is -49.50% and the current price is 500.90% away from 52-week low price. The company has Relative Strength Index (RSI 14) of 41.11 together with Average True Range (ATR 14) of 0.42.
Past 5 years growth of CRON observed at N/A, and for the next five years the analysts that follow this company is expecting its growth at N/A. The stock’s price to sales ratio for trailing twelve months is 144.15 and price to book ratio for the most recent quarter is 15.43, whereas price to cash per share for the most recent quarter are N/A. Its quick ratio for the most recent quarter is N/A. Analysts mean recommendation for the stock is N/A. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Disclaimer: Any news, report, research, and analysis published on Alphabetastock.com are only for information purposes. Alpha Beta Stock (ABS) makes sure to keep the information up to date and correct, but we didn’t suggest or recommend buying or selling of any financial instrument unless that information is subsequently confirmed on your own. Information in this release is fact checked and produced by competent editors of Alpha Beta Stock; however, human error can exist.